- Johnson & Johnson
- Guidant Corp.
- Medtronic PLC
- Cordis Corp.
- Boston Scientific Corp.
- Ethicon Inc.
- Cook Group Inc.
- Angiotech Pharmaceuticals Inc.
- Novartis AG
- DePuy Synthes
- Abbott Laboratories Inc.
- St. Jude Medical Inc.
- Cameron Health Inc.
- Merck & Co. Inc.
- Eli Lilly & Co.
- Amgen Inc.
- Genentech Inc.
- Gilead Sciences Inc.
- Biogen Inc.
- AstraZeneca PLC
- Schering-Plough Corp.
- Pfizer Inc.
- J&J withdraws offer to acquire Guidant
- Medtronic acquires Arterial Vascular Engineering for $3.5bn
- Medtronic acquires Sofamor Danek for $3.6bn
- Medtronic acquires MiniMed for $48/share
- J&J buys Cordis, builds force in vascular disease management
- Guidant to co-promote Cordis's drug-eluting stent
- Guidant to buy Cook for up to $3bn; terminated
- Cook, Guidant develop drug-coated stents; terminated
- Cook licenses rights to paclitaxel from Angiotech
- Guidant gets co-exclusive rights to Novartis antibiotic
- Boston Scientific invests, may buy Cameron Health
- Sanofi-Synthélabo closes takeover of Aventis
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.